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Abstract 
The leaves of Scurrula parasitica were effectively extracted by means of cold extraction method. 
Fractionation and purification of the n-hexane, ethyl acetate, and methanol crude extracts yielded 
eight compounds. These compounds were identified as quercetin (1), quercitrin (2), kaempferol 3-O-
-L-rhamnoside (3), (+)-catechin (4), lupeol (5), lupeol palmitate (6), -sitosterol (7), and squalene
(8). Compounds 1, 4, 5, and 6 were investigated for anticonvulsant potentials using maximal
electroshock test (MEST) in chicks and pentylenetetrazole-induced seizure test in mice while the
effect of the compounds on motor coordination was investigated using beam walking assay. The
compounds did not completely protect the mice against pentylenetetrazole-induced seizure, but
increased the mean onset of myoclonic jerks and spasms in the animals. Quercetin (1) significantly (p
< 0.05) increased the mean onset of spasm in the unprotected animals. The compounds also
differentially protected the mice against mortality. Conversely, the compounds did not protect the
chick against the MEST. Similarly, they did not significantly reduce the recovery time. In the beam
walking assay, the increase in the number of foot slips observed in the study may be associated with
the interaction of quercetin (1) and (+)-catechin (4) with the GABA system to produce clinical
sedation. The findings of the present study suggest that the isolated compounds possess some mild
anticonvulsant potential and may be beneficial in the management of petit mal epilepsy.
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INTRODUCTION 
Epilepsy is a common and diverse brain condition characterized 
mainly by persistent and unpredictable disruptions of normal brain 
function [1]. The term seizures refer to a temporary change of 
behaviour due to irregular coordinated, and recurring burst firing of 
neuronal populations in the central nervous system (CNS). Another 
studies characterize seizures by frequent unpredictable impulsive 
convulsions caused by traumatic, metabolic, infectious, tumoral, or 
idiopathic (hereditary predisposition) conditions [2-3]. An incomplete 
seizure starts in a confined brain region; however, generalized 
seizures show prevalent participation of both hemispheres from the 
start.  
Epilepsy is regularly managed, but not healed with treatment [3-
4]. Numerous patient with epilepsy failed to have adequate control of 
their seizures despite the optimal use of available anti-epileptic drugs 
(AEDs) in the market. However, over 30% of individuals with 
epilepsy do not have seizures control even with the best available 
treatment, other patients do so at the expense of substantial toxic 
effects such as teratogenicity, hepatotoxicity, and adverse effects on 
cognition and behaviour [1,5]. Natural products originated from the 
marvel of biodiversity in which the interactions among creatures and 
their environment formulate the distinct complex chemical entities 
within the organisms that enrich their existence and competitiveness 
[6-7]. An estimated 25 % of medicinal drugs and 11 % of drugs 
considered fundamental by the WHO are originated from plants and 
many artificial drugs are obtained from plant-based precursor 
compounds [8]. The approximation available shows that, there are at 
least 250,000 species of plants in the world and of the obtainable 
statistics, about 150,000 of them are found in the tropics. In south east 
Asia alone, there are 35,000 species of which 8,000 are found in 
Malaysia. Until now, at least 654 species have been reported to 
possess medicinal values in the tropics. From this, a total of 1,230 
species have been reported in Malaysia as medicinal plants which are 
used in traditional medicine [9-11]. Currently, many scientists are 
attempting to identify more plants which have medicinal values and 
the potential to be commercialized as herbal medicines. Loranthaceae 
is one of the plant family which are believed to have high medicinal 
values due to its wide use in many traditional medicine.    
Generally called mistletoe, Scurrula parasitica L. is a member of 
the Loranthaceae family that is represented by 75 genera and 1000 
species. The plant has several local uses and is widely distributed in 
Asia, Australia, and South America [12]. It is a semi-parasitic shrub 
with woody stem. The leaves are simple, stringy, and evergreen. 
Timbered suckers often regarded as adventitious roots connects to and 
infiltrate the branches of the host tree or shrub by a structure called 
the haustorium, through which they absorb water and nutrients from 
the host tree [13]. The leaves of genus Scurrula are used for the 
treatment of disease like cancer, malaria, and hypertension [14]. It 
also has common application in treating infusion for fatigue and 
cancer in Indonesia and Java [15]. Interestingly, the anticonvulsant 
activity of the ethyl acetate fraction of a mistletoe plant Globimetula 
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braunii has been reported [16]. The two earlier investigations on the 
chemical constituents of Scurrula parasitica from China led to the 
isolation of several secondary metabolites [17-18]. Considering the 
importance of the therapeutic uses of these genera in the management 
of cancer, malaria, and hypertension, it is clear that a wider range of 
investigations on the biological activities are needed to be discovered 
for their pharmacological properties. Since the promising source of 
novel, safe, and active anticonvulsant substances appears to be plants, 
the present study therefore aimed at isolating the bioactive compounds 
from the leaves of Scurrula parasitica and test the compounds for 
anticonvulsants using pentylenetetrazole-induced seizure test, beam 
walking assay in mice, and maximal electroshock test in chicks 
(MEST). 
MATERIAL AND METHODS 
Collection and identification of plant material 
The fresh leaves of S. parasitica parasite on Pongamia pinnata 
were collected from Universiti Teknologi Malaysia (UTM), Southern 
Malaysia (Latitude N 1o 33' 54.9'', Longitude E 7o 103', 29.2'') in 
August 2016. They were confirmed and authenticated at the 
Department of Landscape Architect, Faculty of Design and 
Architecture, Universiti Putra Malaysia, where the voucher specimens 
(No SK2800/17) for S. parasitica and (SK28001/17) for P. pinnata 
were compared with the existing specimens by Dr. Shamsul Khamis. 
Extraction and isolation 
The plant leaves were washed with clean water then air dried 
under the shade for several weeks. The dried leaves were then ground 
using laboratory grinder. The powdered plant material (1.4 kg) was 
extracted using cold extraction method using different polarity of 
solvents starting with n-hexane, EtOAc, and MeOH at room 
temperature for three days. The samples were concentrated on a rotary 
evaporator to obtain black gummy crude extracts of n-hexane, EtOAc, 
and MeOH. The fractionation and purification of n-hexane (SPPPH), 
ethyl acetate (SPPPE), and methanol (SPPPM) crude extracts were 
carried out using vacuum liquid chromatography (VLC), column 
chromatography (CC), preparative thin layer chromatography, and 
thin layer chromatography (TLC). Purification of SPPPE was 
conducted by repeated CC over SiO2 with n-hexane: EtOAc as eluents 
afforded quercetin (1). The methanol extract, SPPPM was subjected to 
VLC (SiO2 600 g, 10.0 cm  10.0 cm) and eluted with 
CHCl3:EtOAc:MeOH in stepwise gradient followed by CC over SiO2 
to afford quercitrin (2), kaempferol 3-O--L-rhamnoside (3), and (+)-
catechin (4). The n-hexane extract was fractionated by VLC over SiO2 
(600 g, 10.0 cm  10.0 cm) and eluted with n-hexane: CHCl3: EtOAc 
in stepwise gradient followed by CC over SiO2 with n-hexane: EtOAc 
as eluents to yield lupeol (5), lupeol palmitate (6), β-sitosterol (7), and 
squalene (8). The structures were determined using spectroscopic 
method including IR, NMR, MS, and comparison with reported data. 
Experimental animals 
Adult Swiss Albino mice of either sex (18-24 g) were used in this 
experiment. They were acquired from the Animal House Facility of 
the Department of Pharmacology and Therapeutics, ABU, Zaria. Day 
old white Rangers cockerels were obtained from the National Animal 
Production Institute (NAPRI), Shika, Kaduna, Nigeria. They were 
conserved at 23.0 ± 2.0 ℃, 12 h light and dark circle, fed with 
standard rodent feed, and water was provided ad libitum. They were 
kept in polypropylene cages throughout the study. All experimental 
protocol complied with the National institute of Health Guide for the 
Care and Use of Laboratory Animals (Publication No 5-23, revised 
1985). All experimental protocols were approved by the Departmental 
Ethical Committee and an Ethical Approval Number DAC/W-
OT/301-27 was obtained. 
Maximal Electroshock Seizures Test (MEST) in chicks 
The method adopted was consistent with that of Swinyard (1989) 
[19] and White (1995) [20]. The apparatus used was Ugobasile
electroconvulsive machine (Model 7801), with corneal electrodes
placed on the upper eyelids of the chicks. A shock duration, 
frequency, and pulse width were set and kept at 0.8 s, 100 pulses/sec 
and 0.8 m/s respectively. A current of 75 mA which produced tonic 
seizures in 95 % of the control chicks was used throughout the study. 
Groups of chicks (n=10) were administered with normal saline (10 
mL/kg), isolated compound (30, 100, and 300 mg/kg) and phenytoin 
(20 mg/kg) thirty minutes prior to the administration of shock. An 
incident of tonic extension of the hind limbs was regarded as full 
convulsion and the recovery time was recorded in unprotected 
animals, while lack of tonic extension of the hind limbs was regarded 
as protection. 
Fig. 1  Graphic picture of chicks after delivery of electroshock seizure. 
Pentylenetetrazole induced seizure (PTZ) in mice 
The PTZ (CD97) test exploits a dose of pentylenetetrazole (85 
mg/kg) to induce clonic convulsions that produces clonic seizures 
lasting for a period of at least five seconds in 95 % of the tested 
animals. Mice were divided into five groups (n = 6): the first group 
was pre-treated with normal saline (10 mL/kg); three groups of six 
mice each were given 300 mg/kg, 100 mg/kg, and 30 mg/kg body 
weight of the isolated compound, respectively; and the last group of 
six mice was pre-treated with sodium valproate (200 mg/kg) and 
served as positive control. After 30 minutes post-treatment, the 
convulsant was administered subcutaneously and the animals were 
individually monitored for the presence or absence of clonic spasm (of 
at least five seconds duration) to determine the compound ability to 
abolish the effect of pentylenetetrazol on seizures threshold [19]. The 
onset of twitching and myoclonic jerks were also recorded. 
Fig. 2  Mice after seizure induced by sc-PTZ. 
Beam walking assay (neuro toxicity) 
This protocol was based on the method previously described [21]. 
Mice were tested for the ability to walk on a cylindrical beam. Before 
the trial, the mice were trained to walk across a horizontal beam (a 
meter long and 3 cm wide) elevated 30 cm above the table with the 
aid of two metallic supports. Three trials were performed for each 
mice, and were designed such that the mice would be aware of a goal 
box placed at the end of the beam. Trained mice were randomly 
divided into groups of six mice each. The animals were treated with 
normal saline (10 mL/kg), isolated compound (30 mg/kg, 100 mg/kg 
and 300 mg/kg), or diazepam (1 mg/kg). After 30 minutes post-
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treatments, mice were placed at one end of a cylindrical beam (80 cm 
long and 8 mm in diameter). The number of foot slips as well as time 
taken to complete the task (i.e time taken to poke into the entrance of 
the goal box) with a maximum time of 60 s allowed on the beam. For 
the mice fell, they were returned to the position where they fell from.  
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Fig. 3  Chemical structures of compounds 1-8 isolated from the leaves 
of S. parasitica. 
RESULTS AND DISCUSSION 
The main source of plant-based traditional medical practices arose 
from the investigative trial and error by man for centuries through 
palatability tests morbidity and mortality, while seeking nearby food 
for treatment of illnesses. Naturally occurring medicinal plants have 
been well acknowledged for their therapeutic uses for centuries. They 
have progressed and adapted over millions of years to endure insects, 
microbes, and weather to generate distinct, structurally varied 
secondary metabolites. The active principles of many drugs found in 
plants are composed of these secondary metabolites.   
Table 1 Effect of compounds obtained from Scurrula parasitica against 
maximal electroshock in mice. 
Compounds 
Treatment 
mg/kg 
Quantal 
protection 
Mean time of 
recovery (Min) 
Normal saline 10 ml/kg 0/10 3.94± 0.58 
Quercetin 100 1/10 5.52± 0.91 
30 0/10 6.57± 0.36 
10 0/10 6.47± 1.41 
(+)-Catechin 100 0/10 7.28± 0.87 
30 0/10 5.1± 0.67 
10 0/10 5.16± 0.48 
Lupeol 100 0/10 8.17±0.80 
30 0/10 6.24±1.06 
10 0/10 6.53±1.24 
Lupeol 
palmitate 
100 0/10 6.52±0.99 
30 0/10 5.25±0.93 
10 0/10 6.44±0.52 
Phenytoin 20 20 9/10 6.92± 0.00 
Protection against seizure expressed as percentages, mean onset of seizure is 
expressed as mean  SD, p < 0.05 (compared with normal saline treated control), 
n=10 
The fractionation and purification of n-hexane (SPPPH: 27 g 1.87 
%), ethyl acetate (SPPPE: 32 g, 2.20%), and methanol (SPPPM: 45 g, 
3.10%) crude extracts led to the isolation of eight compounds which 
were identified as quercetin 1 (8 mg 0.13 % as yellow powder with Rf 
0.56 in n-Hexane: EtOAc, 2:3, and m.p 300–302 ℃ ) [22]; quercitrin 2 
(7 mg, 0.02 % as a yellow solid; Rf 0.62, CHCl3: MeOH, 4.2:0.8, and 
m.p 176–178 ℃ ) [23]; kaempferol 3-O--L-rhamnoside 3 (7.5 mg,
0.02 % as a yellow powder; Rf 0.65, CHCl3: MeOH, 4.2:0.8 and m.p
171–174 ℃ ) [24]; (+)-catechin 4 (9.2 mg, 0.02% as a pale brown
powder with m.p. 174–176 ℃  and Rf value of 0.45 in n-hexane:
EtOAc 1:4) [25]; lupeol 5 (28 mg, 0.52 % as a white powder; Rf 0.67
n-Hexane: EtOAc, 4:1 and m.p. 214–216 ℃ ) [26]; lupeol palmitate 6 
(243 mg, 4.50 % as white waxy solid; Rf 0.23 n-Hexane:Et2O, 4.6:0.4
and m.p 79–81 ℃ ) [27]; -sitosterol 7 (174 mg, 3.22% as white
crystalline needles; Rf 0.45 n-Hexane: EtOAc, 4.2:0.8 and m.p 132–
134 ℃ ) [28]; and squalene 8 (151 mg, 0.34% as white waxy powder
with Rf 0.78 n-Hexane: EtOAc, 4.9:0.1) [29]. These plants-derived
secondary metabolites are flavonoids and triterpenes which lately
have drawn attention because of their anticonvulsant effect. The
effects of flavonoids on nervousness [30], depression [31], learning
and memory processes [32-34], and nociception [35] have been
reported. Also, betulinic acid obtained from extract of
Marcgraviaceae showed anti-anxiety activity after oral and
intraperitoneal administration in mice and rats [36].
Table 2 Effect of compounds obtained from Scurrula parasitica against 
pentylenetetrazole induce seizure. 
Compounds 
Treatment 
mg/kg 
Quantal 
protection 
against 
seizure 
Mean 
onset of 
myoclonic 
jerk (Min) 
Mean 
onset of 
Seizure 
(Min) 
Normal 
saline 
10 mL/kg 0/6 2.17± 
0.46 
5.71± 
1.05 
Quercetin 100 0/6 5.14± 
1.34* 
13.55 ± 
2.50* 
30 2/6 5.44 ± 
0.93* 
12.97 
±1.69* 
10 0/6 4.7± 
0.89* 
9.69± 
1.79* 
(+)-Catechin 100 2/6 4.17± 
0.20* 
10.85± 
1.28* 
30 1/6 4.51± 
1.41* 
9.35± 
1.02* 
10 1/6 5.02± 
1.83* 
9.37± 
2.83* 
Lupeol 100 0/6 5.09 ± 
1.29* 
9.34 ± 
1.30* 
30 0/6 3.28 ± 
0.99* 
9.66± 
2.20 
10 0/6 3.27 ± 
0.61* 
5.94± 
1.26 
Lupeol 
palmitate 
100 1/6 4.15± 
0.55* 
4.59 ± 
1.93 
30 2/6 3.94 
±0.87* 
4.37 ± 
1.06 
10 1/6 4.00 ± 
0.87* 
5.70 ± 
0.89 
Sodium 
valproate 
200 6/6 4.14± 
0.00* 
21.21± 
0.00 
Data presented as Mean ± SD; p < 0.05 (Dunnet post hoc test for multiple 
comparison); n= 6. 
The MEST test is believed to be a standard model for generalized 
tonic-clonic seizures that is exceptionally reproducible with reliable 
endpoints. The behavioral and electrographic seizures produced by 
MEST are reliable with the human disorder [19]. In the MEST test, all 
of the control animals exhibited seizure after the delivery of 
electroshock. The four compounds tested (except quercetin at 100 
mg/kg body weight that gives 10% protection) did not protect the 
animals against tonic hind limbs extension in all the tested doses. 
However, mortality of the tested animals was not recorded for the 
entire compounds tested. The compounds that inhibit seizure spread 
(active in the MEST) are known to be sodium channel blockers such 
as carbamazepine, felbamate, phenytoin, and valproate or agents that 
block glutamatergic neurotransmission mediated by N-methyl-D-
aspartate (NMDA) receptors [20; 37-38]. The absence of 
anticonvulsant activity in MEST (Table 1) indicates that, the tested 
compounds may not be suitable in the management of generalized 
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tonic clonic and partial seizures. Meanwhile, pentylenetetrazole is the 
recognized chemoconvulsant used for evaluating antiepileptic drugs 
that triggers seizures by blocking the chloride channel coupled to the 
main GABAA receptor complex or shown to interact with GABA 
neurotransmitters. Thus, it has been used to identify compounds that 
raise the seizure threshold in brain [39-40]. Drugs such as diazepam 
and phenobarbitone that are considered as standard antiepileptic drugs 
that produces their effect by enhancing GABA mediated inhibition in 
the brain are protective against pentylenetetrazole-induced seizure. 
Ethosuximide can also block seizures induced by sc-PTZ by reducing 
t-type calcium currents [41].  
 
Table 3 Effect of compounds obtained from Scurrula parasitica on 
motor coordination in mice.  
 
Compounds 
Treatment 
(mg/kg) 
Number of 
foot slips 
Time taken 
to complete 
the tasks 
(Secs) 
Normal saline 10 mL/kg 0.33±0.21 19.04±0.55 
Quercetin  100 4.15± 0.55* 18.60±0.34 
 
30 4.7± 0.89* 17.16±0.27 
10 5.14± 1.34* 18.01±0.16 
(+)-Catechin  100 4.17± 0.20* 11.51±0.45 
 
30 4.51± 1.41* 15.17±0.43 
10 5.02± 1.83* 12.33±0.02 
Lupeol 100 0.33±0.33 13.33±4.36 
 30 0.33±0.21 17.33±6.12 
  10 0.33±0.33 11.67±6.23 
Diazepam 2  4.67±1.09* 60±0.00* 
Data presented as Mean ± SD; p < 0.001 (Dunnet post hoc test for multiple 
comparison); n= 6 
 
In the PTZ-induced seizure in mice, almost all of the control 
animals displayed myoclonic jerk, while some exhibited threshold 
seizure and loss of righting reflex with tonic forelimbs extension. 
However, all of the tested compounds prolong the onset of myoclonic 
jerking, spasm, seizure, and the time of death in the unprotected 
animals (Table 2). The abilities of all the tested compounds to delay 
the onset of myoclonic jerks, spasm, and/or time of death are also 
indicative of some mild to moderate protective effects. The mild 
anticonvulsant activity observed may also involve the augmentation of 
GABAergic neurotransmission, dopaminergic mechanism, inhibition 
of t-type calcium current, or blockade of glutamatergic 
neurotransmission mediated by NMDA receptors [42]. The 
functioning on the balance beam is a valuable measure of good 
coordination and balance, and can identify motor shortfalls due to age, 
central nervous system lesions, genetic, and pharmacological 
manipulations in young and older rodents in the beam walking assay 
(Table 3) [43-45]. In identifying motor coordination shortfalls 
stimulated by diazepam, the beam test was subtler than the rotarod. 
Stanley [21] indicated that only a 30 % GABAA receptor occupancy 
of diazepam was required to observed motor shortfalls on the beam 
compared to 70 % receptor occupancy for shortfalls on the rotarod. 
The foot slips and time taken to complete the task are very sensitive 
measures of determining benzodiazepine-like drugs induced motor 
coordination deficits and adequately predict clinical sedation 
involving GABAergic neurotransmission [21]. Previously, quercetin 
and catechin have been variously reported to enhance GABAergic 
neurotransmission and promote sleeps [46-47]. Therefore, the increase 
in the number of foot slips observed in the study may be associated 
with the interaction of these agents with the GABA system to produce 
clinical sedation. The anticonvulsant effect of quercetin and lupeol in 
animal models of seizure and their anticonvulsant properties were in 
accordance with previous investigations demonstrated in mice. 
Nieoczym et al. [48], have reported the weak and short term dose 
dependent anticonvulsant action of quercetin (400 mg/kg) against 6 
Hz model psychomotor seizure induces by MEST and PTZ in mice. 
The compounds significantly increased the seizure threshold for 6 Hz 
induced seizure, but did not completely influence the seizure threshold 
in both MEST and PTZ tests in mice. Additionally, an observed 
anticonvulsant effect of quercetin at specific dose (50 mg/kg) against 
PTZ induced seizure was reported by Nassiril-Asl et al. [34]. The 
result showed an enhanced memory retrieval in the passive avoidance 
task and also increased oxidative stress in the kindled animals. It also 
attenuates seizure severity from the beginning of the kindling 
experiment by lowering the mean seizure stage and significantly 
increase the step through latency of the passive avoidance response 
compared to the control in the retention test. The observation that 
lupeol showed very weak to in active anticonvulsant activity was in 
conformity with the earlier published data by Ruta and colleagues in 
2008 [49], that lupeol does not bound to GABAA receptor. No data 
was found on the anticonvulsant activity of lupeol palmitate. As such, 
these results have furthermore guided to a better understanding of its 
anticonvulsant activity.  
 
CONCLUSION 
 
The findings of the present study suggested that the isolated 
compounds possess some mild anticonvulsant potential which may be 
beneficial in petit mal epilepsy and further offered pharmacological 
basis for the ethnomedicinal use of the plants from this family in the 
management of convulsion and epilepsy. This is also the first report of 
the anticonvulsant effect of lupeol palmitate.  
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